Emerging Markets Account For Increasing Percentage Of Merck KGaA Sales

Germany-based drugmaker Merck KGaA has posted Q210 revenues of US$2.89bn, a 5.20% increase on Q110 revenues (US$2.74bn) and 16.10% increase on revenues of US$2.49bn in Q209. Merck's Q210 operating profit figures reached a value of US$426.29mn, a 10.65% increase from Q110 profits of US$385.26mn and a 76.80% increase from Q209 profits of US$241.11mn. The significant increase in operating profit compared with Q209 is attributable to the acquisition of Millipore in 2010.

To read the full article, please choose one of the following options: